Comparing two diabetes drugs for treating PCOS-related infertility
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial compares two medicines, vildagliptin and metformin, to see which is better at helping women with polycystic ovary syndrome (PCOS) get pregnant. It is for women who are struggling to conceive and do not have diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 40 years old
- You have been diagnosed with PCOS
- You have not been able to get pregnant (either never or after previous pregnancies)
- You have not taken hormone therapy, birth control pills, or weight loss drugs for at least 8 weeks
- You have not used anti-androgen medicines for hirsutism (like finasteride) for at least 4 weeks
- You do not have diabetes, liver or kidney disease, or a recent heart attack or stroke
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medicines, vildagliptin and metformin, to see which works better for women with Polycystic Ovary Syndrome (PCOS). The goal is to find a safe and effective treatment that may help manage PCOS symptoms.
This study compares two medicines—dapagliflozin and metformin—to see which works better for women with PCOS who are trying to get pregnant. Both drugs may help improve hormone balance and ovulation, but they work differently.
This study tests whether a class of diabetes drugs called GLP-1 receptor agonists can improve fertility in overweight women with polycystic ovary syndrome who want to conceive. These drugs help with weight and blood sugar, which may improve ovulation and pregnancy chances.
This trial tests if sitagliptin or BeiDouGen capsule can improve pregnancy outcomes in women with PCOS. It aims to help those planning to conceive or struggling with infertility.
This trial tests whether a class of drugs called GLP-1 receptor agonists (often used for diabetes and weight loss) can improve pregnancy outcomes in women with polycystic ovary syndrome (PCOS) who are overweight or obese. If you have PCOS and a BMI between 28 and 35, you may be eligible to participate.
This study is testing different ways of using the medicine metformin to help women with PCOS manage their symptoms and improve their health. If you are overweight and have PCOS, this trial may help find the best dose for you.
Hear when a new Poly Cystic Ovary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.